Latest News

PQ Bypass Reports Positive 12-Month Results.

Milpitas, California.  28 June 2018.  Results from the DETOUR I Trial evaluating the PQ Bypass DETOUR System for percutaneous bypass showed promising 12-month durability for patients with extremely long blockages in the superficial femoral artery (SFA). […]

Read more

Quanta Successfully Completes Pilot Treatments in France.

Alcester, UK.  25 April 2018.  Seroba’s investee company Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions, has announced that it has successfully completed a clinical pilot to treat […]

Read more

Prexton Acquired by Lundbeck for up to €905m.

Oss, The Netherlands & Dublin, Ireland.  16 March 2018.  H. Lundbeck A/S (Lundbeck) and Seroba’s Investee Company, Prexton Therapeutics BV (Prexton), today announced the signing of a definitive agreement in which Lundbeck will acquire Prexton. Under […]

Read more

Doctors Perform ‘Bypass’ Without Surgery.

Little Rock, Arkansas.  2 March 2018.  Seroba’s investee company, PQ Bypass was making eye-catching headlines in the USA this week.  Arkansas Heart Hospital is the first U.S. hospital to perform the DETOUR procedure and the story […]

Read more

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top